BioMarin Pharmaceutical (BMRN) reported first-quarter 2025 adjusted earnings per share of $1.13, which beat the Zacks Consensus Estimate of 94 cents. Quarterly earnings rose 59% year over year, driven by higher product sales and lower operating expenses.Total revenues were $745 million, which rose 15% year over year on a reported basis and 17% on a constant-currency basis. The top line beat the Zacks Consensus Estimate of $737 million. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar) ...

PTC Therapeutics (PTCT) Update / Briefing July 19, 2023 12:00 PM ET Speaker0 Thank you for standing by, and welcome to the PTC Therapeutics PKU Deep Dive. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you'll need to press 11 on your telephone. As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, Kylie O'Keefe, chief commerc ...